Diabetes

Addition of sotagliflozin for T1DM alters renal hemodynamics

(HealthDay)—Sotagliflozin (SOTA), a dual sodium-glucose cotransporter 1 inhibitor (SGLT1i) and SGLT2i, is associated with short- and long-term renal hemodynamic changes in patients with type 1 diabetes, according to a study ...

Diabetes

Similar metabolic response to animal, plant protein diets

(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), isocaloric diets high in animal protein (AP) or plant protein (PP) are associated with similar improvements in metabolism and cardiovascular risk factors, according ...

Diabetes

Parathyroid hormone linked to arterial stiffness in T1DM

(HealthDay)—In individuals with type 1 diabetes, parathyroid hormone (PTH) is associated with arterial stiffness, even after adjustment for multiple confounding variables, according to research published online Jan. 6 in ...

Cardiology

Albuminuria predicts cardiovascular outcome after PCI

(HealthDay)—An elevated urinary albumin excretion rate can predict adverse cardiovascular outcomes in patients undergoing elective percutaneous coronary intervention, according to a study published in the March 1 issue ...

Diabetes

n-3 PUFA may reduce markers of kidney disease in T2DM

(HealthDay)—In patients with type 2 diabetes and evidence of kidney injury, supplementation with n-3 long-chain polyunsaturated fatty acids (PUFA) does not reduce urine albumin excretion but is associated with a reduction ...

page 1 from 2